TABLE 3.
Antisense oligonucleotides for IBD treatment | |
Target of AONs | Administration approach |
Intracellular adhesion molecule-1 (alicaforsen) (Jairath et al., 2017) | Intravenous, rectal |
Inhibition of Smad7 (mongersen) (Boirivant et al., 2006) | Oral |
NF-κBp65 (Murano et al., 2000) | Intracolonic |
Blocking CD154/CD40 interactions (Gao et al., 2005) | Intracolonic |
TNF-α (Duan et al., 2019) | Oral |